BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7542786)

  • 1. Risperidone augmentation of clozapine.
    McCarthy RH; Terkelsen KG
    Pharmacopsychiatry; 1995 Mar; 28(2):61-3. PubMed ID: 7542786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.
    Se Hyun Kim ; Dong Chung Jung ; Yong Min Ahn ; Yong Sik Kim
    J Psychopharmacol; 2010 Jul; 24(7):981-6. PubMed ID: 19942641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is risperidone a substitute for clozapine for patients who do not respond to neuroleptics?
    Lacey RL; Preskorn SH; Jerkovich GS
    Am J Psychiatry; 1995 Sep; 152(9):1401. PubMed ID: 7544546
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone in adolescents.
    Cozza SJ; Edison DL
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1211. PubMed ID: 7527022
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antipsychotic medications: do research results relate to clinical practice?
    MacEwan GW
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel neuroleptics in schizophrenia: theory and clinical relevance.
    Remington GJ
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of treatment-resistant patients with schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical review of risperidone.
    Chouinard G; Arnott W
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone (R64 766) in psychotic patients. A first clinical therapeutic exploration.
    Roose K; Gelders Y; Heylen S
    Acta Psychiatr Belg; 1988; 88(3):233-41. PubMed ID: 2466393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.
    Chouinard G; Vainer JL; Bélanger MC; Turnier L; Beaudry P; Roy JY; Miller R
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1129-41. PubMed ID: 7531355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone: clinical safety and efficacy in schizophrenia.
    Borison RL; Pathiraja AP; Diamond BI; Meibach RC
    Psychopharmacol Bull; 1992; 28(2):213-8. PubMed ID: 1381102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].
    Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.